MYX mayne pharma group limited

To be realistic I'm not expecting NPAT 15% for the next 1-2...

  1. 7,702 Posts.
    lightbulb Created with Sketch. 630
    To be realistic I'm not expecting NPAT 15% for the next 1-2 years, as the ship is just turning.
    Sustainable Revenue growth is the most significant sign of positive, outlook suggest FY25 will way overpass the $400-450m revenue mark, as revenue increase the Direct Opex will be substantially lower and the margin will rise further.
    Also the 2nd half net loss includes the $33m settlement payout and the Earn-out payment, so the real loss is much lower.
    When approach NPAT break-even the ratio of less than 1 ( revenum $400-450m vs MC $370)will be screamingly cheap.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.34
Change
0.120(2.30%)
Mkt cap ! $433.8M
Open High Low Value Volume
$5.29 $5.34 $5.15 $705.4K 133.2K

Buyers (Bids)

No. Vol. Price($)
2 2000 $5.31
 

Sellers (Offers)

Price($) Vol. No.
$5.34 3653 3
View Market Depth
Last trade - 16.10pm 18/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.